META vs MRK: Which Is the Better Buy?
Side-by-side comparison of Meta Platforms, Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
Meta Platforms, Inc. · Communication Services
$665.60
+21.4% upside to fair value
Med Conviction
Grade B+
High Quality
VS
Merck & Co., Inc. · Healthcare
$147.17
-4.1% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
META has more upside to fair value
(+21.4%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
META |
MRK |
| Current Price |
$665.60 |
$147.17 |
| Fair Value Estimate |
$808.00 |
$141.07 |
| Upside to Fair Value |
+21.4%
|
-4.1%
|
| Market Cap |
$1,695.6B |
$363.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
16.7x
|
29.6x
|
| Price / Sales |
7.4x
|
5.5x
|
| Price / FCF |
41.3x
|
22.6x
|
| Revenue Growth YoY |
+28.0%
|
+5.1%
|
| Gross Margin |
81.7%
|
75.4%
|
| Operating Margin |
38.1%
|
16.7%
|
| Return on Equity |
29.7%
|
6.6%
|
| Dividend Yield |
0.32% |
2.31% |
| FCF Yield |
2.42%
|
4.42%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Meta Platforms operates the Facebook, Instagram, WhatsApp, Messenger and Threads ecosystem, monetizing its unmatched global audience primarily through digital advertising. Business quality is high, supported by 3.60 billion Family daily active people, AI-enhanced ad ranking, 81.7% TTM gross margin, 38.1% TTM operating margin, 29.8% TTM net margin and 29.7% ROE. Revenue grew 28.0% year over year i…
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
Accumulation Zones
| Metric |
META |
MRK |
| Zone Low |
$606.00 |
$105.80 |
| Zone High |
$686.80 |
$119.91 |
| In Buy Zone? |
Yes
|
No
|